Topical application of dynorphin A (1-17) antiserum attenuates trauma induced alterations in spinal cord evoked potentials, microvascular permeability disturbances, edema formation and cell injury: An experimental study in the rat using electrophysiological and morphological approaches

Amino Acids

Volumn 23, Issue 1-3, 2002, Pages 273-281

  Winkler, T ^a   Sharma, H S ^b   Gordh, T ^a   Badgaiyan, R D ^b,c   Stalberg E ^a   Westman, J ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Amino acids; Dynorphin antiserum; Edema; Spinal cord evoked potentials; Spinal cord injury; Ultrastructure

Indexed keywords

DYNORPHIN A; DYNORPHIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD VESSEL PERMEABILITY; CELL DAMAGE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; EDEMA; ELECTROPHYSIOLOGY; EVOKED RESPONSE; EVOKED SPINAL CORD RESPONSE; HISTOPATHOLOGY; MALE; MICROVASCULATURE; MORPHOLOGY; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY;

ANIMALS; ANTIBODIES; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; DYNORPHINS; EDEMA; EVOKED POTENTIALS; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD INJURIES;

ANIMALIA;

EID: 0036392024     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-001-0138-y     Document Type: Conference Paper

References (42)

1. Amir S (1982) Opiate antagonists improve survival in anaphylacic shock. Eur J Pharmacol 80: 161-162
2. Björklund A, Hökfelt T, Kuhar MI (1990) Neuropeptides in the CNS, Part II. Handbook Chem Neuroanat 9: 1-538
3. Civelli O, Douglass J, Goldstein A, Herbert E (1985) Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci USA 82: 4291-4295
4. Chahl LA, Chahl JS (1986) Plasma extravasation induced by dynorphin (1-13) in rat skin. Eur J Pharmacol 124: 343-347
5. Chavkin C, Goldstein A (1981) Specific receptors for the opiod peptide dynorphin: structure activity relationships. Proc Natl Acad Sci USA 78: 6543-6548
6. Cho HJ, Basbaum AI (1989) Ultrastructural analysis of dynorphin B-immunoreactive cells and terminals in the superficial dorsal horn of the deafferented spinal cord of the rat. J Comp Neurol 281: 193-201
7. Chen L, Gu Y, Huang L-YM (1995) The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat. J Physiol (London) 482: 575-581
8. Duggan AW, Fleetwood-Walker SM (1993) Opioids and sensory processing in the central nervous system. Handbook Exp Pharmacol 104 (II): 731-771
9. Evans CJ, Hammond DL, Frederickson RCA (1988) The opioid peptides. In: Pasternak GW (ed) The opiate receptors. Humana, Clifton, pp 23-71
10. Faden AI (1990) Opioid and non-opioid mechanisms may contribute to dynorphin's pathophysiological actions in the spinal cord injury. Ann Neurol 27: 64-74
11. Faden AI (1993) Role of endogenous opioids and opioid receptors in central nervous system injury. Handbook Exp Pharmacol 104 Part I: 325-341
12. Faden AI (1996) Neurotoxic versus neuroprotective actions of endogenous opioid peptides: Implications for treatment of CNS injury. NIDA Res Mongr 163: 318-330
13. Faden AI, Takemori AE, Portoghese PS (1987) Kappa-selective opiate antagonist norbinaltorphine improves outcome after traumatic spinal cord injury in rats. Cent Nerv Syst Trauma 4: 227-237
14. Fallon JH, Ciofi P (1990) Dynorphin-containing neurons. Handbook Chem Neuroanat 9: 1-286
15. Fleetwood-Walker SM, Hope PJ, Mitchell R, El-Yassir N, Molony V (1988) The influence of opioid receptor subtypes on the processing of nociceptive inputs in the spinal dorsal horn of the cat. Brain Res 451: 213-226
16. Gaumann DM, Grabow TS, Yaksh TL, Casy SJ, Rodriguez M (1990) Intrathecal somatostatin analogs, substance P analog and dynorphin A cause comparable neurotoxicity in rats. Neuropharmacology 39: 761-774
17. Han J, Xie G (1984) Dynorphin: important mediator for electroacupuncture analgesia in the spinal cord of the rabbit. Pain 18: 367-376
18. Hauser KF, Knapp PE, Turbek CS (2001) Structure-activity analysis of dynorphin A toxicity in spinal cord neurons: Intrinsic neurotoxicity of dynorphin A and its carboxyl-terminal, nonopioid metabolites. Exp Neurol 168: 78-87
19. Hökfelt T, Elde R, Goldstein M, Nilsson G, Pernow B, terenius L, ganten D, Jeffocate SL, Rechfeld J, Said S (1978) Distribution of peptide containing neurons. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 39-66
20. Isaac L, O'Malley TVZ, Ristic H, Stewart P (1990) MK-801 blocks dynorphin A (1-13)-induced loss of the tail flick reflex in the rat. Brain Res 531: 83-87
21. Iadarola MJ, Brady LS, Draisci G, Dubner R (1988) Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: Stimulus specificity, behavioural parameters and opioid receptor binding. Pain 35: 313-326
22. Long JB, Martinez-Arizala A, Echevarria EE, Tidwell RE, Holaday JW (1988) Hindlimb paralytic effects of prodynorphin-derived peptides follwoing spinal subarachnoid injection in rats. Eur J Pharmacol 153: 45-54
23. Long JB, Rigamonti DR, deCosta B, Rice KC, Martinez-Arizala A (1989) Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the κ-opioid antagonist norbinaltorphimine. Brain Res 497: 155-162
24. Long JB, Rigamonti DD, Oleshansky MA, Wingfield CP, Martinez-Arizala A (1994) Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of spinal cord injury. J Pharmacol Exp Ther 296: 358-366
25. Nichols ML, Lopez Y, Ossipov MH, Bian D, Porreca F (1997) Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphin by antisera to dynorphin A (1-13) or MK-801 in nerve-ligation model of peripheral neuropathy. Pain 69: 317-322
26. North RA (1993) Opioid actions on membrane ion channels. Handbook Exp Pharmacol 104 (II): 773-797
27. Nyberg F, Sharma HS, Wiesenfeld-Hallin Z (1995) Neuropeptides in the spinal cord. Prog Brain Res 104: 1-416
28. Sharma HS (1987) Effect of captopril (a converting enzyme inhibitor) on blood-brain barrier permeability and cerebral bloodflow in normotensive rats. Neuropharmacology 26: 85-92
29. Sharma HS (1999) Pathophysiology of blood-brain barrier, brain edema and cell injury following hyperthermia: new role of heat shock protein, nitric oxide and carbon monoxide. An experimental study in the rat using light and electron microscopy. Acta Universitatis Upsaliensis 830: 1-94
30. Sharma HS, Olsson Y (1990) Edema formation and cellular alterations following spinal cord injury in rat and their modification with p-chlorophenylalanine. Acta Neuropathologica (Berlin) 79: 604-610
31. Sharma HS, Winkler T, Stålberg E, Olsson Y, Dey PK (1991) Evaluation of traumatic spinal cord edema using evoked potentials recorded from the spinal epidural space. An experimental study in the rat. J Neurol Sci 102: 150-162
32. Sharma HS, Nyberg F, Olsson Y (1992) Dynorphin A content in the rat brain and spinal cord after a localized trauma to the spinal cord and its modification with p-chlorophenylalanine. An experimental study using radioimmunoassay technique. Neuroscience Research 14: 195-203
33. Sharma HS, Olsson Y, Nyberg F (1995) Influence of dynorphin-A antibodies on the formation of edema and cell changes in spinal cord trauma. Prog Brain Res 104: 401-416
34. Sharma HS, Alm P (2002) Nitric oxide synthase inhibitors influence dynorphin A (1-17) immunoreactivity in the rat brain following hyperthermia. Amino Acids 23: 247-259
35. Sharma HS, Winkler T (2002) Assessment of spinal cord pathology following trauma using early changes in the spinal cord evoked potentials. A pharmacological and morphological study in the rat. Muscle and Nerve (in press)
36. Smith AP, Lee MN (1988) Pharmacology of dynorphin. Ann Rev Pharmacol Toxicol 28: 123-140
37. Stålberg E, Sharma HS, Olsson Y (1998) Spinal cord monitoring. Basic principles, regeneration, pathophysiology and clinical aspects. Springer, Wien New York, pp 1-527
38. Sydbom A, Terenius L (1985) The histamine releasing effect of dynorphin and other opioid peptides possessing arg-pro sequences. Agents Actions 16: 269-272
39. Tang Q, Lynch RM, Porreca F, Lai J (2000) Dynorphin A elicits an increase in intracellular calcium in cultured neurons via a non-opioid, non-NMDA mechanims. J Neurophysiol 83: 2610-2615
40. Weisskopf MG, Zalutsky RA, Nicoll RA (1993) The opioid peptide dynorphin mediates hetrosynaptic depression of hippocampalmossy fibre synapses and modulates long-term potentialtion. Nature 362: 423-427
41. Winkler T, Sharma HS, Stålberg E, Olsson Y, Nyberg F (1994) Opioid receptors influence spinal cord electrical activity and edema formation following spinal cord injury. Experimental observations using naloxone in the rat. Neurosci Res 21: 91-101
42. Winkler T, Sharma HS, Stålberg E, Westman J (1998) Spinal cord bioelectrical activity, edema and cell injury following a focal trauma to the spinal cord. An experimental study using pharmacological and morphological approach. In: Stålberg E, Sharma HS, Olsson Y (eds) Spinal cord monitoring, Springer, Wien New York, pp 281-348